HOME › DRUGS › DOSTARLIMAB-GXLY
ACTIVE SUBSTANCE / INN

DOSTARLIMAB-GXLY

Brand name(s): JEMPERLI
FDA LISTED
PRESCRIPTION
BLA761223
ACTIVE SUBSTANCE
Dostarlimab-Gxly
REGULATORS
FDA
SPONSORS / MAH
GLAXOSMITHKLINE LLC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
JEMPERLIBLA761223GLAXOSMITHKLINE LLCPrescription

FULL INTELLIGENCE ON DOSTARLIMAB-GXLY

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →